Trials / Conditions / Ann Arbor Stage III Mantle Cell Lymphoma
Ann Arbor Stage III Mantle Cell Lymphoma
3 registered clinical trials studyying Ann Arbor Stage III Mantle Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CH NCT07444710 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma NCT02489123 | University of Washington | Phase 2 |
| Active Not Recruiting | Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mant NCT02494700 | M.D. Anderson Cancer Center | Phase 2 |